Movira, Reymond J.
HRN: 23-14-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2024
CEFTRIAXONE 1G (VIAL)
06/04/2024
06/11/2024
IV
2g
Q24
Partial Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes